Altre lingue Takeda Pharmaceutical Company Limited Deutsche Boerse AG

Azioni

TKDA

US8740602052

Mercato chiuso - Deutsche Boerse AG Altri mercati azionari 08:18:11 07/06/2024			Variaz. 5gg	Var. 1 gen.
12,2 ^EUR	+0,83%		+3,39%	-3,17%

06/06	L'unità farmaceutica Takeda collabora con HEALWELL AI per l'analisi delle prove reali dell'angioedema ereditario	MT
06/06	Torrent Pharma firma un accordo con la giapponese Takeda per commercializzare un farmaco per i disturbi acidi in India	MT

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Takeda Pharmaceutical : Statement from Masami Iijima, Chair of the Board of Directors Meeting of Takeda, in Response to Institutional Shareholder Services Inc.’s Voting Recommendations Ahead of the 148th Ordinary General Meeting of Shareholders Form 6 K	07/06
Former Takeda Employee Pleads Guilty to Defrauding Company	06/06
Takeda Pharmaceutical Unit Partners with HEALWELL AI for Real-World Evidence Analysis of Hereditary Angioedema	06/06
Torrent Pharma Signs Deal with Japan's Takeda to Market Acid-Related Disorders Drug in India	06/06
Takeda Pharmaceutical - Notice Concerning Withdrawal of Shelf Registration Statement and Filing of New Shelf Registration Statement in Japan	04/06
Takeda Pharmaceutical, Pfizer Say Phase 3 Trial Assessing Blood Cancer Combination Therapy Met Co-Primary Endpoints	03/06
Takeda Says Narcolepsy Drug Meets Main, Secondary Goals in Trial	03/06
Takeda Pharmaceutical Company Limited to Present Positive Results from its Phase 2B Trial of TAK-861	03/06
Takeda’s TAK-861 Phase 2b Late-Breaking Data Presentations at SLEEP 2024 Demonstrate Clinically Meaningful Impact of Oral Orexin Agonist in Narcolepsy Type 1 Compared to Placebo	03/06
GSK blood cancer drug nearly halves risk of death in late-stage trial	02/06
Takeda and Pfizer Announce Four-Year Results from Positive Phase 3 HD21 Trial of Additional ADCETRIS (brentuximab vedotin) Combination in Frontline Hodgkin Lymphoma	01/06
Takeda Pharmaceutical Says Recombinant ADAMTS13 Gets Approval Recommendation From European Medicines Agency's CHPM	31/05
Takeda Gets CHMP Approval for Recombinant ADAMTS13	31/05
Takeda Receives Positive CHMP Opinion for Recombinant ADAMTS13 (rADAMTS13) in Congenital Thrombotic Thrombocytopenic Purpura (cTTP)	31/05
Takeda Receives Positive CHMP Opinion for Recombinant ADAMTS13 in Congenital Thrombotic Thrombocytopenic Purpura	31/05
Pharmakonzern Takeda plant Abbau von bis zu 120 Stellen in Opfikon	31/05
BHP pursuit of Anglo American highlights corporate-led UK M&A upswing	30/05
Takeda Pharmaceutical : Other items which are provided electronically	29/05
Evotec steigt aus Gentherapie-Geschäft aus - Ergebniseinbruch zum Jahresstart	22/05
TAKEDA PHARMACEUTICAL : Form 6-K	21/05

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Takeda Pharmaceutical Company Limited Deutsche Boerse AG

Azioni

TKDA

US8740602052

Altre lingue

Filtri